CSL
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WA
CSL Limited (CSL) is a global biotechnology company that develops and delivers innovative medicines that save lives, protect public health and help people with life-threatening medical conditions live full lives. CSL is also involved in research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. CSL's operating model for its two businesses, CSL Behring and Seqirus.
Contact Details
45 Poplar Rd, Parkville, PARKVILLE VIC 3052
03 9389 1911
Lists and Charts
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 13th |  | CSL | $13,333.5m |
| 15th | | News Corporation | $13,138.6m |
| 16th |  | Worley | $13,058.0m |
| 18th |  | Downer EDI | $12,742.7m |
| 19th | | Macquarie Group | $12,414.0m |
1217 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 26/02/21
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 755th | News Corporation | 55% | 13% |
| 1198th | Macquarie Group | 8% | 23% |
| 1430th | Downer EDI | -6% | 15% |
| 1463rd | Worley | -9% | 25% |
| 1531st | CSL | -14% | 22% |
1741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Article Timeline
Company Activity
| NEWS: Tagged in Hunt stands by October virus vaccine goal | 02 Mar 2021 |
| NEWS: Tagged in Experts doubt October vaccination target | 01 Mar 2021 |
| NEWS: Tagged in CSL says vaccine manufacture accelerated | 18 Feb 2021 |
| NEWS: Tagged in COVID vaccine program receives $1.9bn boost | 01 Feb 2021 |
| NEWS: Tagged in WA not immune to outbreak affliction | 31 Jan 2021 |
| NEWS: Tagged in Six weeks of gains on ASX, but banks slip | 11 Dec 2020 |
| NEW ROLE: Karen Etchberger, General Business | 25 Nov 2020 |
| NEW ROLE: Andrew Cuthbertson, Chief Research Officer | 25 Nov 2020 |
| NEW ROLE: L Reed, | 24 Nov 2020 |
| NEW ROLE: Robert Repella, Former Commercial Manager | 24 Nov 2020 |
